C07D 313/08
Condensed with one six-membered ring
Official title: condensed with one six-membered ring
C07D313/08 (Condensed with one six-membered ring) appears on 147 US grants and 88 published applications in this corpus.
Search patents in C07D- Granted patents
- 147
- Published applications
- 88
- Assignees
- 78
- Inventors
- 398
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 5 | 0 |
| 1980 | 6 | 0 |
| 1981 | 6 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 3 | 0 |
| 1989 | 5 | 0 |
| 1990 | 3 | 0 |
| 1991 | 4 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 4 | 0 |
| 2000 | 7 | 0 |
| 2001 | 5 | 1 |
| 2002 | 7 | 3 |
| 2003 | 4 | 3 |
| 2004 | 1 | 2 |
| 2005 | 3 | 1 |
| 2006 | 2 | 5 |
| 2007 | 0 | 5 |
| 2008 | 5 | 5 |
| 2009 | 2 | 9 |
| 2010 | 8 | 3 |
| 2011 | 5 | 9 |
| 2012 | 7 | 3 |
| 2013 | 3 | 5 |
| 2014 | 3 | 3 |
| 2015 | 4 | 5 |
| 2016 | 1 | 2 |
| 2017 | 1 | 1 |
| 2018 | 2 | 2 |
| 2019 | 1 | 2 |
| 2020 | 2 | 3 |
| 2021 | 2 | 2 |
| 2022 | 3 | 3 |
| 2023 | 1 | 3 |
| 2024 | 3 | 3 |
| 2025 | 3 | 3 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Enzyme-mediated process for making Amberketal and Amberketal homologues24 Mar 2026US 12,584,153 B2Givaudan SA
- Mitochondrial permeability transition pore (mPTP)-opening inhibitor, novel compound exhibiting mPTP-opening inhibitory activity, and use therefor10 Feb 2026US 12,544,354 B2Riken
- Estrogen receptor-modulating compounds16 Dec 2025US 12,497,386 B2Radius Pharmaceuticals, Inc.
- Compositions and methods for visible-light-controlled ruthenium-catalyzed olefin metathesis5 Aug 2025US 12,377,407 B2The Trustees of Columbia University in the City of New York
- Inhibitors of nitric oxide synthases (NOS), pharmaceutical products thereof, and methods thereof10 Jun 2025US 12,325,681 B2Gacter Inc.
- Compounds for the Treatment of Neuromuscular Disorders16 Jul 2026US 2026/0199273 A1Nmd Pharma A/S
- Compounds and compositions and uses thereof5 Feb 2026US 2026/0035381 A1PGI Drug Discovery LLC
- Radiation-sensitive composition, method for forming pattern, and radiation-sensitive acid generator27 Nov 2025US 2025/0362596 A1Jsr Corporation
- Process for the preparation of compounds comprising a 2,5-dihydrobenzoxepine structure by photochemical rearrangement15 May 2025US 2025/0154122 A1Centre National De La Recherche Scientifique
- Improved methods and enzymes23 Jan 2025US 2025/0027126 A1Givaudan SA
Most cited
By later US patents
- Synthesis of aryl ethers88US 5,847,166 AMassachusetts Institute of Technology · 1998
- Synthesis of aryl ethers71US 6,166,226 AMassachusetts Institute of Technology · 2000
- Guanidine derivatives66US 6,346,527 B1Fujisawa Pharmaceutical Co., Ltd. · 2002
- Benzofuran and dihydrobenzofuran melatonergic agents65US 5,856,529 ABristol-Myers Squibb Company · 1999
- Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases59US 5,059,609 APfizer Inc. · 1991